A Test Before An Approved Therapy: Inbiomotion MAFTEST Is Tackling Breast Cancer Metastases
Executive Summary
Bisphosphonate drugs, commonly prescribed to treat osteoporosis, have been linked to a reduction in breast cancer metastases in women. Inbiomotion is developing a test to expand the population eligible for this adjuvant therapy.